Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:54 AM
Ignite Modification Date:
2025-12-25 @ 4:54 AM
NCT ID:
NCT00530218
Eligibility Criteria:
Inclusion Criteria:
DISEASE CHARACTERISTICS:
* Undergoing allogeneic transplantation, including unrelated donor bone marrow transplantation (BMT) and/or allogeneic donor leukocyte infusion, for any indication
* Patients or their donors must have had a positive pre-BMT cytomegalovirus (CMV) antibody titer as measured by enzyme-linked immunosorbent assay (ELISA)
PATIENT CHARACTERISTICS:
* Able to comply with study requirements
Exclusion criteria:
* Signs or symptoms of documented CMV infection, including any positive CMV culture from any site and/or any suspected or documented CMV-associated clinical syndrome, at the time of study entry
* History of symptomatic CMV-associated clinical syndrome
PRIOR CONCURRENT THERAPY:
* Receiving concurrent investigational antiviral agents
PATIENT CHARACTERISTICS:
* History of hypersensitivity to ganciclovir or acyclovir
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00530218
Study Brief:
Protocol Section:
NCT00530218